Acorn Capital Advisors, LLC
Acorn Capital Advisors, LLC is an independent investment adviser headquartered in New York, NY, United States. Founded in 2011, the firm focuses on managing pooled investment vehicles, specifically venture capital funds concentrating in the biotechnology and life sciences sectors. With a team of 5 employees, all focused on investment activities, Acorn Capital Advisors manages over $239 million in assets for pooled vehicles including Acorn BioVentures LP and Acorn BioVentures 2 LP.
Investment Strategy
Acorn Capital Advisors, LLC employs a venture capital investment strategy with a strong focus on biotechnology and life sciences companies. The firm primarily operates pooled investment vehicles that seek early-stage and growth-stage opportunities in medical, pharmaceutical, and innovative healthcare businesses. Acorn's portfolios show a significant allocation to biopharma and medtech equities, leveraging a team with deep domain expertise to identify high-potential companies in the sector. The strategy emphasizes long-term capital appreciation by investing in innovative firms expected to benefit from major advancements in life sciences.
Top Holdings
Equity Positions (21)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
C CGON | CG ONCOLOGY INC | 19.24% | $29.4M | 1,131,501 | $28.68 | $26.00 | +$1.7M |
U URGN | UROGEN PHARMA LTD | 11.29% | $17.3M | 1,259,749 | $10.65 | $13.70 | +$488.2K |
Y YMAB | Y-MABS THERAPEUTICS INC | 10.09% | $15.4M | 3,418,995 | $7.28 | $4.51 | +$1.1M |
P PBYI | PUMA BIOTECHNOLOGY INC | 9.27% | $14.2M | 4,131,299 | $3.07 | $3.43 | +$2.5M |
C CADL | CANDEL THERAPEUTICS INC | 8.54% | $13.1M | 2,580,517 | $7.83 | $5.06 | +$897.2K |